Author Index

Search or browse for an author across our entire electronic archive

Search results for: P
Results 21 - 30 of 1472 shown below

  • Paavonen, J

    M Hinkula, E Pukkala, P Kyyrönen, P Laukkanen, P Koskela, J Paavonen, M Lehtinen and A Kauppila

    A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland

    doi:10.1038/sj.bjc.6601650

  • L L Villa, R L R Costa, C A Petta, R P Andrade, J Paavonen, O-E Iversen, S-E Olsson, J Høye, M Steinwall, G Riis-Johannessen, A Andersson-Ellstrom, K Elfgren, G von Krogh, M Lehtinen, C Malm, G M Tamms, K Giacoletti, L Lupinacci, R Railkar, F J Taddeo, J Bryan, M T Esser, H L Sings, A J Saah and E Barr

    High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

    advance online publication, 2006-11-21 00:00:00.000;

    doi:10.1038/sj.bjc.6603469

  • Paavonen, T

    O Tynninen, J Sjöström, K von Boguslawski, N O Bengtsson, R Heikkilä, P Malmström, B Østenstad, E Wist, V Valvere, E Saksela, T Paavonen and C Blomqvist

    Tumour microvessel density as predictor of chemotherapy response in breast cancer patients

    doi:10.1038/sj.bjc.6600325

  • Pabot du Chatelard, P

    A Villers, P Pommier, A Bataillard, B Fervers, J M Bachaud, N Berger, A F Bertrand, R Bouvier, D Brune, A Daver, E Fontaine, O Haillot, J L Lagrange, V Molinie, J P Muratet, P Pabot du Chatelard, M Peneau, D Prapotnich, V Ravery, P Richaud, D Rossi and M Soulie

    Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)

    doi:10.1038/sj.bjc.6601084

  • Pabst, T

    B U Mueller, T Pabst, P Hauser, G Gilliland, D Neuberg and D G Tenen

    Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia

    advance online publication, 2006-05-30 00:00:00.000;

    doi:10.1038/sj.bjc.6603198

  • B U Mueller, T Pabst, P Hauser, G Gilliland, D Neuberg and D G Tenen

    Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia

    doi:10.1038/sj.bjc.6603264

  • T Pabst, M Eyholzer, J Fos and B U Mueller

    Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis

    advance online publication, 2009-03-10 00:00:00.000;

    doi:10.1038/sj.bjc.6604977

  • Pace, A

    M Reni, F Zaja, W Mason, J Perry, E Mazza, M Spina, R Bordonaro, F Ilariucci, M Faedi, G Corazzelli, P Manno, E Franceschi, A Pace, M Candela, A Abbadessa, C Stelitano, G Latte and A J M Ferreri

    Temozolomide as salvage treatment in primary brain lymphomas

    advance online publication, 2007-02-27 00:00:00.000;

    doi:10.1038/sj.bjc.6603660

  • Pacella-Norman, R

    R Pacella-Norman, M I Urban, F Sitas, H Carrara, R Sur, M Hale, P Ruff, M Patel, R Newton, D Bull and V Beral

    Risk factors for oesophageal, lung, oral and laryngeal cancers in black South Africans

    doi:10.1038/sj.bjc.6600338

  • Pache, L

    W Kuhn, B Schmalfeldt, L Pache, U Berger, K Ulm, N Harbeck, K Späthe, P Dettmar, H Höfler, F Jänicke, M Schmitt and H Graeff

    Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

    doi:10.1038/sj.bjc.6690278

  • Pacheco, J M

    D Dingli, F A C C Chalub, F C Santos, S Van Segbroeck and J M Pacheco

    Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells

    advance online publication, 2009-09-01 00:00:00.000;

    doi:10.1038/sj.bjc.6605288

  • D Dingli, F A C C Chalub, F C Santos, S Van Segbroeck and J M Pacheco

    Reply: Evolutionary game theory: lessons and limitations, a cancer perspective

    advance online publication, 2009-11-17 00:00:00.000;

    doi:10.1038/sj.bjc.6605445

  • Paci, E

    E Paci, S W Duffy, D Giorgi, M Zappa, E Crocetti, V Vezzosi, S Bianchi and M Rosselli del Turco

    Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990–96

    doi:10.1038/sj.bjc.6600301

  • S Ciatto, M Rosselli Del Turco, P Burke, C Visioli, E Paci and M Zappa

    Comparison of standard and double reading and computer-aided detection (CAD) of interval cancers at prior negative screening mammograms: blind review

    doi:10.1038/sj.bjc.6601356

  • S Ciatto, C Visioli, E Paci and M Zappa

    Breast density as a determinant of interval cancer at mammographic screening

    doi:10.1038/sj.bjc.6601548

  • L Bucchi, A Barchielli, A Ravaioli, M Federico, V De Lisi, S Ferretti, E Paci, M Vettorazzi, S Patriarca, A Frigerio and E Buiatti

    Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size

    advance online publication, 2004-12-14 00:00:00.000;

    doi:10.1038/sj.bjc.6602289

  • L Bucchi, A Barchielli, A Ravaioli, M Federico, V De Lisi, S Ferretti, E Paci, M Vettorazzi, S Patriarca, A Frigerio and E Buiatti

    Reply: An inverse association between tumour size and overdiagnosis may explain the results by Bucchi et al

    advance online publication, 2005-04-26 00:00:00.000;

    doi:10.1038/sj.bjc.6602583

  • M Zorzi, D Puliti, M Vettorazzi, V De Lisi, F Falcini, M Federico, S Ferretti, I F Moffa, L Mangone, M P Mano, C Naldoni, A Ponti, A Traina, R Tumino and E Paci

    Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997–2001)

    advance online publication, 2006-10-17 00:00:00.000;

    doi:10.1038/sj.bjc.6603405

  • D Puliti, G Miccinesi, N Collina, V De Lisi, M Federico, S Ferretti, A C Finarelli, F Foca, L Mangone, C Naldoni, M Petrella, A Ponti, N Segnan, A Sigona, M Zarcone, M Zorzi, M Zappa and E Paci

    Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction

    doi:10.1038/sj.bjc.6604532

  • D Puliti, G Miccinesi, N Collina, V De Lisi, M Federico, S Ferretti, A C Finarelli, F Foca, L Mangone, C Naldoni, M Petrella, A Ponti, N Segnan, A Sigona, M Zarcone, M Zorzi, M Zappa and E Paci

    Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction

    doi:10.1038/sj.bjc.6604779

  • Pacilio, C

    C Pacilio, A Morabito, F Nuzzo, A Gravina, V Labonia, G Landi, E Rossi, E De Maio, M Di Maio, G D'aiuto, G Botti, N Normanno, P Chiodini, C Gallo, F Perrone and A de Matteis

    Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial

    advance online publication, 2006-04-18 00:00:00.000;

    doi:10.1038/sj.bjc.6603096